Drug Coverage
Medicare Part D Donut Hole 2026: Is It Still a Thing?
The Medicare Part D donut hole is effectively gone in 2026 — replaced by a $2,000 annual out-of-pocket cap. Here's what changed and what it means for your drug costs.
Quick Summary
The dreaded 'Donut Hole' coverage gap has officially been eliminated as of 2025. In 2026, beneficiaries benefit from a simplified structure and a hard $2,000 annual out-of-pocket cap.
For decades, the medicare part d donut hole 2026 was the most feared aspect of retirement planning. Seniors who hit the gap would suddenly see their drug costs jump by 400% or more, leading many to skip doses or split pills. Thankfully, the Inflation Reduction Act has finally closed this chapter, offering a more predictable and affordable path for prescription coverage.
The History and Death of the Donut Hole
When Part D was created in 2006, it included a gap in coverage. After you and your plan spent a certain amount, you were responsible for a high percentage of drug costs until you reached the 'catastrophic' level. Over the years, legislation slowly reduced the percentage seniors paid in the gap, but it wasn't until 2025 that the structure was completely overhauled.
How Part D Costs Changed 2023-2026
Max out-of-pocket spending for high-cost drug users
| 2023 (No Cap) | $7,400 (Estimated) |
| 2024 (No Cap) | $8,000 (Estimated) |
| 2025 ($2k Cap) | $2,000 |
| 2026 ($2k Cap) | $2,000 |
2024 vs. 2026: Cost Phase Comparison
| Phase | Old System (Before 2025) | New System (2026) |
|---|---|---|
| Deductible | You pay 100% up to limit | You pay 100% up to $590 |
| Initial Coverage | You pay 25% coinsurance/copay | You pay 25% coinsurance/copay |
| Coverage Gap | The 'Donut Hole' (You pay 25%) | REPLACED by Initial Coverage |
| Catastrophic | You paid 5% (Before 2024) | YOU PAY $0 |
The $2,000 Win
The $2,000 cap is the biggest Part D win in years, resulting in savings of thousands of dollars for seniors taking high-cost specialty drugs for cancer, rheumatoid arthritis, or MS.
How the New $2,000 Cap Works
In 2026, the out-of-pocket cap includes your deductible and any copays or coinsurance you pay at the pharmacy. It does NOT include your monthly premiums. Once your total spending hits $2,000, the pharmacy system will automatically drop your copay to $0 for every covered drug for the rest of the year.
Exclusions Still Apply
Only 'covered' drugs count toward the $2,000 cap. If you use a drug that isn't on your plan's formulary, or an excluded drug like a weight-loss medication, those costs will not help you reach the cap.
What Counts (and Doesn't Count) Toward the $2,000 Cap
| Payment Type | Counts Toward $2,000 Cap? |
|---|---|
| Your deductible payments | ✓ Yes |
| Your copays/coinsurance at the pharmacy | ✓ Yes |
| Insulin ($35/month cap payments) | ✓ Yes |
| Monthly Part D premiums | ✗ No |
| GoodRx or cash purchases (outside your plan) | ✗ No |
| Non-formulary / excluded drugs | ✗ No |
| Manufacturer coupons applied at pharmacy | Varies — check your plan |
Track Your Progress at Medicare.gov
Log into your Medicare account at Medicare.gov to track your running total toward the $2,000 cap. You can also call 1-800-MEDICARE to ask for your current out-of-pocket total at any time during the year.
The Monthly Cost Smoothing Option
New for 2025/2026, you can opt into the 'Prescription Payment Plan' — a CMS program that lets you spread your out-of-pocket Part D costs evenly over the year in monthly installments. Instead of paying a large amount up front in January (before your cap kicks in), you pay consistent amounts each month. This is especially helpful for those who take high-cost specialty drugs and face large pharmacy bills early in the year.
Enroll in the Smoothing Option Through Your Plan
Contact your Part D plan directly or log in to your member portal to opt into the Prescription Payment Plan. It's voluntary and free — there's no fee to spread your costs. Changes take effect the following month.
Insulin: Capped at $35/Month Per Prescription
Since 2023, Medicare-covered insulin has been capped at $35 per month per covered prescription — regardless of your plan's formulary or tier. This applies to all insulin products covered under Part D as well as insulin covered under Part B (administered by a doctor). You pay no more than $35 even before meeting your deductible.
Insulin Cap Applies Before the Deductible
Unlike most Part D drugs, insulin's $35 cap applies even in the deductible phase. You never pay more than $35/month for each insulin prescription — and these payments count toward your $2,000 annual out-of-pocket cap.
Who Benefits Most From the New Cap?
The $2,000 cap provides the greatest relief to beneficiaries taking expensive specialty drugs — particularly those treating cancer, multiple sclerosis, rheumatoid arthritis, hepatitis C, and other serious conditions. Previously, a cancer patient could face $10,000–$15,000 or more per year in out-of-pocket drug costs. Now that exposure is capped at $2,000, making catastrophic medication costs a thing of the past for Medicare enrollees.
Key Takeaways
- ✓The Part D donut hole has been officially eliminated for 2026.
- ✓Your total out-of-pocket drug costs are capped at $2,000 annually.
- ✓After hitting the $2,000 limit, you pay $0 for the rest of the year.
- ✓This change primarily benefits those taking expensive brand-name drugs.
- ✓Monthly premiums do not count toward the $2,000 out-of-pocket limit.
- ✓The 'Prescription Payment Plan' can help you spread the $2,000 over 12 months.
Frequently Asked Questions
Disclaimer: SeniorPop is not affiliated with Medicare, Medicaid, or any government agency. Benefit availability varies by plan and location. Contact a licensed Medicare advisor for plan-specific information.